BPC-157 is supplied strictly for laboratory research purposes and is not approved for human or veterinary use
One such concerning trend is the use of BPC-157, a peptide that has been increasingly promoted by compounding pharmacies and some medical practitioners as a treatment for musculoskeletal injuries
Understanding these differences helps medical aestheticians select the ideal approach for each patient, balancing efficacy, comfort, and potential risks
Oral and capsule versions are less studied and may require higher doses for comparable results
[3] GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring peptide in human plasma, saliva, and urine that declines with age
For patients dealing with stubborn soft-tissue injuries, post-surgical recovery, or chronic inflammation, either peptide is worth discussing with a qualified provider